# CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

> **NCT01386502** · PHASE1 · WITHDRAWN · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Breast Cancer
- Colon Cancer
- Pancreatic Cancer
- Sarcoma
- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** p53: 264-272 peptide
- **DRUG:** CT-011

## Key facts

- **NCT ID:** NCT01386502
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-06-15
- **Primary completion:** —
- **Final completion:** 2011-10-31
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386502, "CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01386502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*